These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 14504)

  • 1. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
    Kralberg BE; Tolagen K
    Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.
    Karlberg BE; Kågedal B; Tegler L; Tolagen K; Bergman B
    Am J Cardiol; 1976 Mar; 37(4):642-9. PubMed ID: 769527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
    Bravo EL; Tarazi RC; Dustan HP
    N Engl J Med; 1975 Jan; 292(2):66-70. PubMed ID: 234005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol in the control of blood pressure: a dose-response study.
    Serlin MJ; Orme ML; Baber NS; Sibeon RG; Laws E; Breckenridge A
    Clin Pharmacol Ther; 1980 May; 27(5):586-92. PubMed ID: 6102895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].
    Weidmann P; Beretta-Piccoli C; Ziegler W; Hirsch D; de Châtel RD; Reubi FC
    Klin Wochenschr; 1976 Aug; 54(16):765-73. PubMed ID: 8663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.
    Leonetti G; Mayer G; Morganti A; Terzoli L; Zanchetti A; Bianchetti G; Di Salle E; Morselli PL; Chidsey CA
    Clin Sci Mol Med Suppl; 1975 Jun; 48(6):491-9. PubMed ID: 1056279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
    Hollifield JW; Sherman K; Zwagg RV; Shand DG
    N Engl J Med; 1976 Jul; 295(2):68-73. PubMed ID: 775330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.
    Karlberg BE; Kågedal B; Tegler L; Tolagen K
    Br Med J; 1976 Jan; 1(6004):251-4. PubMed ID: 764929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of development of the antihypertensive effect of propranolol.
    Fagan TC; Walle T; Corns-Hurwitz R; Conradi EC; Privitera P; Harmon G; Degenhart W; Gaffney TE
    Hypertension; 1983; 5(6):852-7. PubMed ID: 6360868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
    Matsunaga M; Hara A; Ogino K; Motohara S; Saito M
    Jpn Heart J; 1977 Jan; 18(1):24-30. PubMed ID: 15142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol.
    Laragh JH
    Am J Med; 1976 Nov; 61(5):797-810. PubMed ID: 10730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
    Zweifler A; Esler M
    Am J Cardiol; 1977 Jul; 40(1):105-9. PubMed ID: 879001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients.
    Mitchell HC; Pettinger WA
    Clin Pharmacol Ther; 1981 Sep; 30(3):297-302. PubMed ID: 6115731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.
    Stumpe KO; Kolloch R; Vetter H; Gramann W; Krück F; Ressel C; Higuchi M
    Am J Med; 1976 May; 60(6):853-65. PubMed ID: 14499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
    Drayer JI; Kloppenborg PW; Festen J; van't Laar A; Benraad TJ
    Am J Cardiol; 1975 Oct; 36(5):716-21. PubMed ID: 1103606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.